ライフサイエンスコーパス: nonsteroidal

1 ion, we have identified for the first time a nonsteroidal agent that selectively activates beta1-cont

2 lofexor (formerly GS-9674), a small-molecule nonsteroidal agonist of farnesoid X receptor, in patient

3 gimens in patients with prior sensitivity to nonsteroidal AI and in baseline plasma from the PALOMA3

4 MBC whose disease progresses while receiving nonsteroidal AIs.

5 Treatment of bone pain includes nonsteroidal analgesics and opiates; however, long-term

6 d crystal structure of the GR LBD bound to a nonsteroidal antagonist, and this article provides addit

7 igand-binding domain (GR LBD) complex with a nonsteroidal antagonist, compound 8, was determined.

8 d intracellular CYP450 on the removal of six nonsteroidal anti-inflammatories (NSAIs) by Trametes hir

9 drugs in five different classes (uricosuric, nonsteroidal anti-inflammatories, loop diuretics, angiot

10 anti-inflammatory activity compared with the nonsteroidal anti-inflammatory agent ketorolac.

11 ly symptomatic osteoarthritis managed with a nonsteroidal anti-inflammatory agent.

12 k have often included patients using aspirin/nonsteroidal anti-inflammatory agents (NSAIDs) or acid-s

13 Topical nonsteroidal anti-inflammatory agents (NSAIDs) proved to

14 Nonsteroidal anti-inflammatory agents are not associated

15 hol-related conditions), and medication use (nonsteroidal anti-inflammatory agents, corticosteroids,

16 rvations: Regional analgesia, acetaminophen, nonsteroidal anti-inflammatory agents, gabapentinoids, t

17 the relationship between early postoperative nonsteroidal anti-inflammatory drug (NSAID) administrati

18 Inhibition of PGE2 production through nonsteroidal anti-inflammatory drug (NSAID) administrati

19 Reported nonsteroidal anti-inflammatory drug (NSAID) allergies ma

20 l carbonic anhydrase inhibitor in 6 eyes and nonsteroidal anti-inflammatory drug (NSAID) drops in 2 e

21 Nonsteroidal anti-inflammatory drug (NSAID) exacerbated

22 Diclofenac sodium is a widely used nonsteroidal anti-inflammatory drug (NSAID) for relief o

23 en single nucleotide polymorphisms (SNPs) in nonsteroidal anti-inflammatory drug (NSAID) metabolism a

24 In eyes with nonsteroidal anti-inflammatory drug (NSAID) monotherapy

25 tive net arylation of the minimally modified nonsteroidal anti-inflammatory drug (NSAID) naproxen.

26 al prednisolone acetate (PA) alone or with a nonsteroidal anti-inflammatory drug (NSAID) or intraoper

27 y examined whether short-term use of topical nonsteroidal anti-inflammatory drug (NSAID) or steroid t

28 ng body of evidence links certain aspects of nonsteroidal anti-inflammatory drug (NSAID) pharmacology

29 K-80003, a tRXRalpha modulator derived from nonsteroidal anti-inflammatory drug (NSAID) sulindac, su

30 s between the microbiota and indomethacin, a nonsteroidal anti-inflammatory drug (NSAID) that inhibit

31 PT; aspirin/clopidogrel, ticagrelor) but not nonsteroidal anti-inflammatory drug (NSAID) treatment wi

32 l trials have showed no relationship between nonsteroidal anti-inflammatory drug (NSAID) use and AD.

33 Nonsteroidal anti-inflammatory drug (NSAID) use is recom

34 ty analyses by repeating the analyses in non-nonsteroidal anti-inflammatory drug (NSAID) users (n = 3

35 (II)-phenanthroline complexes containing the nonsteroidal anti-inflammatory drug (NSAID), indomethaci

36 This study demonstrates that daily use of a nonsteroidal anti-inflammatory drug (NSAID), which inhib

37 Multitarget nonsteroidal anti-inflammatory drug (NSAID)-carbonic anh

38 tro test to either diagnose or differentiate nonsteroidal anti-inflammatory drug (NSAID)-exacerbated

39 Nonsteroidal anti-inflammatory drug (NSAID)-exacerbated

40 landin E(2) (PGE(2) ) has been postulated in nonsteroidal anti-inflammatory drug (NSAID)-exacerbated

41 Nonsteroidal anti-inflammatory drug (NSAID)-induced urti

42 and anticancer evaluation of novel selenium-nonsteroidal anti-inflammatory drug (Se-NSAID) hybrid mo

43 large effusion or tamponade, and failure of nonsteroidal anti-inflammatory drug [NSAID] treatment) i

44 idence of risk transformation during chronic nonsteroidal anti-inflammatory drug administration, this

45 This approach was employed to prepare a nonsteroidal anti-inflammatory drug analogue.

46 K3 channels (A237T) or by application of the nonsteroidal anti-inflammatory drug flufenamic acid (FFA

47 the fragrance component celestolide and the nonsteroidal anti-inflammatory drug ibuprofen, are descr

48 identified a context-dependent effect of the nonsteroidal anti-inflammatory drug indomethacin (IND) o

49 Diclofenac, a nonsteroidal anti-inflammatory drug inhibiting COX-2, in

50 Baseline and nonsteroidal anti-inflammatory drug reaction clinical da

51 Nonsteroidal anti-inflammatory drug therapy was effectiv

52 ition and systemic vascular dysfunction with nonsteroidal anti-inflammatory drug usage.

53 , be physically active, not smoke, and avoid nonsteroidal anti-inflammatory drug use except aspirin p

54 s and the 2007 recommendation on aspirin and nonsteroidal anti-inflammatory drug use to prevent color

55 ching yielded 6,088 statin user pairs, 2,886 nonsteroidal anti-inflammatory drug user pairs, 1,440 gl

56 r statin users, 1.00 (95% CI, 0.90-1.11) for nonsteroidal anti-inflammatory drug users, 0.97 (95% CI,

57 statin users, 21.3% (95% CI, 19.8-22.9%) for nonsteroidal anti-inflammatory drug users, 17.4% (95% CI

58 Mefenamic acid, a nonsteroidal anti-inflammatory drug, has been identified

59 Rectal indomethacin, a nonsteroidal anti-inflammatory drug, is given to prevent

60 ment goals are not met, a trial of a topical nonsteroidal anti-inflammatory drug, tramadol, or both i

61 methylation and deuteration of nimesulide, a nonsteroidal anti-inflammatory drug, were realized throu

62 Nonsteroidal anti-inflammatory drug-activated gene-1 (NA

63 Some manifestations, such as nonsteroidal anti-inflammatory drug-associated angioedem

64 We examined the role of RGS4 in nonsteroidal anti-inflammatory drug-associated bronchoco

65 Nonsteroidal anti-inflammatory drug-exacerbated respirat

66 uished: NSAID-exacerbated cutaneous disease, nonsteroidal anti-inflammatory drug-induced urticaria/an

67 intestinal injury induced by indomethacin, a nonsteroidal anti-inflammatory drug.

68 he first time both ionization states of this nonsteroidal anti-inflammatory drug.

69 Treatment with a potent non-nonsteroidal anti-inflammatory druglike GSM revealed a n

70 4.81-5.64), steroids (3.18; 2.99-3.39), and nonsteroidal anti-inflammatory drugs (2.37; 2.26-2.48) w

71 ocal anesthesia (31.1% vs 12.9%; P < 0.001), nonsteroidal anti-inflammatory drugs (33.5% vs 14.4%; P

72 lume, followed by topical steroids (86%) and nonsteroidal anti-inflammatory drugs (66%), and accounte

73 rent use of antihypertensive medications and nonsteroidal anti-inflammatory drugs (adjusted odds rati

74 Nonsteroidal anti-inflammatory drugs (e.g. aspirin, ibup

75 tions, and 17 of bronchospasm related to ASA/nonsteroidal anti-inflammatory drugs (NSAID) intake.

76 or alcohol consumption, co-administration of nonsteroidal anti-inflammatory drugs (NSAID) or concomit

77 mide antibiotics (7.4%), opiates (6.8%), and nonsteroidal anti-inflammatory drugs (NSAIDs) (3.5%).

78 19), NAR against aspirin (n = 12) and other nonsteroidal anti-inflammatory drugs (NSAIDs) (n = 8), a

79 ere included: 10 trials evaluated the use of nonsteroidal anti-inflammatory drugs (NSAIDs) (n=4,258)

80 ly to experience IOP spikes than those using nonsteroidal anti-inflammatory drugs (NSAIDs) alone (haz

81 ing acute or chronic pains or inflammations, nonsteroidal anti-inflammatory drugs (NSAIDs) also assoc

82 Concomitant use of nonsteroidal anti-inflammatory drugs (NSAIDs) and low-do

83 Nonsteroidal anti-inflammatory drugs (NSAIDs) are among

84 Nonsteroidal anti-inflammatory drugs (NSAIDs) are assume

85 For treatment of malignant pleural effusion, nonsteroidal anti-inflammatory drugs (NSAIDs) are avoide

86 Nonsteroidal anti-inflammatory drugs (NSAIDs) are effect

87 Nonsteroidal anti-inflammatory drugs (NSAIDs) are effica

88 lusive data about cardiovascular toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs) are sparse

89 Nonsteroidal anti-inflammatory drugs (NSAIDs) are the mo

90 Nonsteroidal anti-inflammatory drugs (NSAIDs) are the mo

91 related anaphylaxis induced by LTPs requires nonsteroidal anti-inflammatory drugs (NSAIDs) as a trigg

92 Clinical Question: Are nonsteroidal anti-inflammatory drugs (NSAIDs) associated

93 Are topical nonsteroidal anti-inflammatory drugs (NSAIDs) associated

94 Are nonsteroidal anti-inflammatory drugs (NSAIDs) associated

95 Nonsteroidal anti-inflammatory drugs (NSAIDs) can damage

96 Nonsteroidal anti-inflammatory drugs (NSAIDs) cause bron

97 to aspirin (acetylsalicylic acid) and other nonsteroidal anti-inflammatory drugs (NSAIDs) constitute

98 Epidemiologic evidence suggests that nonsteroidal anti-inflammatory drugs (NSAIDs) contribute

99 infarction (MI); however, concomitant use of nonsteroidal anti-inflammatory drugs (NSAIDs) could pose

100 drugs such as acetaminophen/paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs) for mild c

101 The role of topical nonsteroidal anti-inflammatory drugs (NSAIDs) for the re

102 Certain rapid reversible, competitive nonsteroidal anti-inflammatory drugs (NSAIDs) have been

103 Nonsteroidal anti-inflammatory drugs (NSAIDs) have many

104 Nonsteroidal anti-inflammatory drugs (NSAIDS) have recei

105 Structural modifications of nonsteroidal anti-inflammatory drugs (NSAIDs) have succe

106 enefit the most from using aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) in relatio

107 Ion-exchange removal of nonsteroidal anti-inflammatory drugs (NSAIDs) in synthet

108 The subcellular mechanism by which nonsteroidal anti-inflammatory drugs (NSAIDs) induce apo

109 Use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) is associa

110 Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) is of grea

111 We evaluated the impact of nonsteroidal anti-inflammatory drugs (NSAIDs) on surviva

112 We sought to evaluate the effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on T-cell

113 escribe the effect of routine use of topical nonsteroidal anti-inflammatory drugs (NSAIDs) on the inc

114 s document for hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) proposed b

115 ND & AIMS: Use of aspirin and/or non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) reduces th

116 Small intestinal damage induced by nonsteroidal anti-inflammatory drugs (NSAIDs) remains an

117 Topical nonsteroidal anti-inflammatory drugs (NSAIDs) significan

118 have demonstrated the remarkable efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) such as ib

119 Targeting of COX-1/2 using nonsteroidal anti-inflammatory drugs (NSAIDs) such as th

120 Although nonsteroidal anti-inflammatory drugs (NSAIDs) target pri

121 racted attention due to prior conjugation to nonsteroidal anti-inflammatory drugs (NSAIDs) to access

122 The ability of nonsteroidal anti-inflammatory drugs (NSAIDs) to inhibit

123 d that acute respiratory infection (ARI) and nonsteroidal anti-inflammatory drugs (NSAIDs) use could

124 Topical steroids and oral nonsteroidal anti-inflammatory drugs (NSAIDs) were used

125 ials evaluating the cardiovascular safety of nonsteroidal anti-inflammatory drugs (NSAIDs) when used

126 back, musculoskeletal injuries with topical nonsteroidal anti-inflammatory drugs (NSAIDs) with or wi

127 The use of nonsteroidal anti-inflammatory drugs (NSAIDs) with oral

128 e placebo-controlled) shows that colchicine, nonsteroidal anti-inflammatory drugs (NSAIDs), and corti

129 e placebo-controlled) shows that colchicine, nonsteroidal anti-inflammatory drugs (NSAIDs), and corti

130 e of proton pump inhibitors (PPIs), aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), and selec

131 Oxicams are widely used nonsteroidal anti-inflammatory drugs (NSAIDs), but littl

132 ribute to enteropathy associated with use of nonsteroidal anti-inflammatory drugs (NSAIDs), but there

133 g modes to equine serum albumin (ESA) of two nonsteroidal anti-inflammatory drugs (NSAIDs), diclofena

134 eview the recent literature on the safety of nonsteroidal anti-inflammatory drugs (NSAIDs), glucocort

135 undreds of millions of people worldwide take nonsteroidal anti-inflammatory drugs (NSAIDs), often in

136 ends that clinicians choose corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), or colchi

137 Nonsteroidal anti-inflammatory drugs (NSAIDs), the medic

138 ve been evaluated for prophylaxis, including nonsteroidal anti-inflammatory drugs (NSAIDs), which are

139 arin with antiplatelet drugs or nonselective nonsteroidal anti-inflammatory drugs (NSAIDs), which fur

140 nisms different from those of agents such as nonsteroidal anti-inflammatory drugs (NSAIDs).

141 ith acute sinusitis compared with placebo or nonsteroidal anti-inflammatory drugs (NSAIDs)?

142 cantly decrease risks for SP included use of nonsteroidal anti-inflammatory drugs (RR, 0.77; 95% CI,

143 antihypertensives, 4 diabetes medications, 2 nonsteroidal anti-inflammatory drugs [NSAIDs] or aspirin

144 hort-term exposure to SSRIs, as is done with nonsteroidal anti-inflammatory drugs and aspirin.

145 Some COX inhibitors (i.e. nonsteroidal anti-inflammatory drugs and coxibs) and com

146 Accordingly, nonsteroidal anti-inflammatory drugs and NADPH oxidase i

147 treated with potassium-sparing diuretics or nonsteroidal anti-inflammatory drugs and oral potassium

148 aged 65 years or older, lack of exposure to nonsteroidal anti-inflammatory drugs and statins.

149 providing access to a variety of enantiopure nonsteroidal anti-inflammatory drugs and to alpha-amino

150 hol and smoking and taking analgesic agents (nonsteroidal anti-inflammatory drugs and weak opioids su

151 Low-molecular-weight heparin and nonsteroidal anti-inflammatory drugs are associated with

152 Oral nonsteroidal anti-inflammatory drugs are not recommended

153 should consider pharmacologic treatment with nonsteroidal anti-inflammatory drugs as first-line thera

154 employment status, and use of analgesics and nonsteroidal anti-inflammatory drugs at 1 and 12 months.

155 r array is able to differentiate six typical nonsteroidal anti-inflammatory drugs at concentrations o

156 ted in the effluent exposome of fish, 6 were nonsteroidal anti-inflammatory drugs but with plasma con

157 hen was ineffective for acute low back pain, nonsteroidal anti-inflammatory drugs had smaller benefit

158 rmance in semiquantitative identification of nonsteroidal anti-inflammatory drugs has been investigat

159 trials (RCTs) showed that oral steroids and nonsteroidal anti-inflammatory drugs have similar analge

160 tended to arylpropionic acids (including the nonsteroidal anti-inflammatory drugs ibuprofen and flurb

161 advances in our understanding of the role of nonsteroidal anti-inflammatory drugs in CRC prevention a

162 Reactions to aspirin and nonsteroidal anti-inflammatory drugs in patients with as

163 Nonsteroidal anti-inflammatory drugs interfere with the

164 Nonsteroidal anti-inflammatory drugs may impair wound he

165 ting that both ionized and neutral states of nonsteroidal anti-inflammatory drugs must be considered

166 BF4)3 and [Ru(NH3)5(L)](BF4)3 containing the nonsteroidal anti-inflammatory drugs nicotinic acid (Hni

167 sired, clinicians and patients should select nonsteroidal anti-inflammatory drugs or skeletal muscle

168 lls with pharmacological inhibitors, such as nonsteroidal anti-inflammatory drugs or small interferin

169 ts include oral contraceptives combined with nonsteroidal anti-inflammatory drugs or surgery to remov

170 ctures (OR, 2.65; 95% CI, 2.34-2.99), use of nonsteroidal anti-inflammatory drugs plus opioids (OR, 1

171 Placebo-controlled trials of nonsteroidal anti-inflammatory drugs selective for inhib

172 to cause cardiovascular adverse effects than nonsteroidal anti-inflammatory drugs specific for inhibi

173 estinal ulcers are common adverse effects of nonsteroidal anti-inflammatory drugs such as acetylsalic

174 Nonsteroidal anti-inflammatory drugs such as sulindac in

175 The use of nonsteroidal anti-inflammatory drugs that inhibit cycloo

176 Nonsteroidal anti-inflammatory drugs use during ARI epis

177 Nonsteroidal anti-inflammatory drugs use during ARI was

178 in PBMCs, and supplementation of cells with nonsteroidal anti-inflammatory drugs was able to restore

179 Subjects with asthma hypersensitive to nonsteroidal anti-inflammatory drugs were compared with

180 Eyes receiving prophylactic nonsteroidal anti-inflammatory drugs were excluded.

181 rt A) or unspecified (cohort B) reactions to nonsteroidal anti-inflammatory drugs were identified as

182 , decreased hematocrit, aspirin therapy, and nonsteroidal anti-inflammatory drugs were independently

183 UV filters, personal sunscreen products, and nonsteroidal anti-inflammatory drugs were seen in both g

184 hese differential effects were ignored, oral nonsteroidal anti-inflammatory drugs were superior.

185 lofenac is one of the most widely prescribed nonsteroidal anti-inflammatory drugs worldwide.

186 (age, sex, smoking, body mass index, use of nonsteroidal anti-inflammatory drugs) and symptoms of ga

187 s), avoidance of potential nephrotoxins (eg, nonsteroidal anti-inflammatory drugs), and adjustments t

188 ions (statins, aspirin, corticosteroids, and nonsteroidal anti-inflammatory drugs), with ulcerated pr

189 rials ranged from 9 (benzodiazepines) to 70 (nonsteroidal anti-inflammatory drugs).

190 g unnecessary medications such as aspirin or nonsteroidal anti-inflammatory drugs).

191 ry reactions to cyclooxygenase-1 inhibitors (nonsteroidal anti-inflammatory drugs).

192 the injection, 14% administer post operative nonsteroidal anti-inflammatory drugs, 28% administer pos

193 asm after the ingestion of aspirin and other nonsteroidal anti-inflammatory drugs, a disorder termed

194 These patients are usually treated with nonsteroidal anti-inflammatory drugs, acetaminophen, opi

195 roxychloroquine, intravenous immunoglobulin, nonsteroidal anti-inflammatory drugs, and cyclosporine,

196 other antihypertensives, aspirin, steroids, nonsteroidal anti-inflammatory drugs, Charlson Comorbidi

197 -opioid interventions such as acetaminophen, nonsteroidal anti-inflammatory drugs, cyclooxygenase-2 i

198 -opioid interventions such as acetaminophen, nonsteroidal anti-inflammatory drugs, cyclooxygenase-2 i

199 is inhibited by ACA as well as the fenamate nonsteroidal anti-inflammatory drugs, flufenamate and ni

200 Preadmission use of statins, nonsteroidal anti-inflammatory drugs, glucocorticoids, o

201 flammatory drugs such as corticosteroids and nonsteroidal anti-inflammatory drugs, often accompanied

202 casionally after the intake of drugs such as nonsteroidal anti-inflammatory drugs, opioids and drugs

203 h DILI (due to acetaminophen, phenprocoumon, nonsteroidal anti-inflammatory drugs, or autoimmune hepa

204 ion single-agent or combined use of statins, nonsteroidal anti-inflammatory drugs, or glucocorticoids

205 Intra-articular treatments were superior to nonsteroidal anti-inflammatory drugs, possibly because o

206 (solid or liquid), and potential cofactors (nonsteroidal anti-inflammatory drugs, protonic pump inhi

207 ave been studied include aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, statins, agents th

208 h-sensitivity C-reactive protein, and use of nonsteroidal anti-inflammatory drugs, statins, and multi

209 ncer, and they are the molecular targets for nonsteroidal anti-inflammatory drugs, which are among th

210 Nonsteroidal anti-inflammatory drugs-induced urticaria/a

211 with short courses of oral contraceptives or nonsteroidal anti-inflammatory drugs.

212 Aryl esters represent an important family of nonsteroidal anti-inflammatory drugs.

213 mPGES-1 inhibitors as a safe alternative to nonsteroidal anti-inflammatory drugs.

214 so demonstrates the synthesis of a number of nonsteroidal anti-inflammatory drugs.

215 esult from the now worldwide availability of nonsteroidal anti-inflammatory drugs.

216 iguanides, sulfonylureas, aspirin, and other nonsteroidal anti-inflammatory drugs.

217 arallel samples were stimulated with related nonsteroidal anti-inflammatory drugs.

218 ion, and prophylaxis against ulceration from nonsteroidal anti-inflammatory drugs.

219 dified by factors such as smoking and use of nonsteroidal anti-inflammatory drugs.

220 vity reactions to beta-lactams, aspirin, and nonsteroidal anti-inflammatory drugs; however, the clini

221 atinocytes, and ACHP is an effective topical nonsteroidal anti-inflammatory in mice.

222 eated postoperatively with topical steroids, nonsteroidal anti-inflammatory medications (NSAIDs), or

223 that was not responsive to over-the-counter nonsteroidal anti-inflammatory medications.

224 ation of two therapeutic drugs, benzydamine (nonsteroidal anti-inflammatory) and tamoxifen (antiestro

225 either open-label enzalutamide or a standard nonsteroidal antiandrogen therapy (standard-care group).

226 Bicalutamide, a nonsteroidal antiandrogen, is widely used to treat men w

227 tion of the triazole core in the scaffold of nonsteroidal antiandrogens allowed the development of sm

228 Most of the commercially available nonsteroidal antiandrogens show a common scaffold consis

229 element in the common A-ring-linkage-B-ring nonsteroidal antiandrogens' general pharmacophore allowe

230 logically active substances (antibacterials, nonsteroidal antiinflammatories, antiseptics, antiepilep

231 The present study compared the effect of the nonsteroidal antiinflammatory drug (NSAID) diclofenac, w

232 estinal damage in zebrafish larvae using the nonsteroidal antiinflammatory drug (NSAID) Glafenine.

233 In the present study, sulindac, a nonsteroidal antiinflammatory drug (NSAID), was tested f

234 indings are potentially game-changing in the nonsteroidal antiinflammatory drug arena.

235 3 effects to blockade by two analgesics (the nonsteroidal antiinflammatory drug ketoprofen and the mu

236 but not postoperative, administration of the nonsteroidal antiinflammatory drug ketorolac and/or reso

237 Aspirin, nonsteroidal antiinflammatory drugs (NSAID), and acetami

238 Among nonusers of nonsteroidal antiinflammatory drugs (NSAIDs) (Pinteracti

239 Although nonsteroidal antiinflammatory drugs (NSAIDs) in general

240 The cardiovascular safety of nonsteroidal antiinflammatory drugs (NSAIDs) may be infl

241 of nine measures of high-risk prescribing of nonsteroidal antiinflammatory drugs (NSAIDs) or selected

242 Acid suppression, nonsteroidal antiinflammatory drugs (NSAIDs), and statin

243 of celecoxib, as compared with nonselective nonsteroidal antiinflammatory drugs (NSAIDs), remains un

244 nd is the therapeutic target for widely used nonsteroidal antiinflammatory drugs (NSAIDs).

245 atechins (naturally occurring flavonols) and nonsteroidal antiinflammatory drugs (NSAIDs).

246 as weight (kg)/height (m)2), never-users of nonsteroidal antiinflammatory drugs, and those with lowe

247 Nonsteroidal antiinflammatory drugs, including ibuprofen

248 mild pain in the thyroid) can be handled by nonsteroidal antiinflammatory drugs.

249 d arthritis (RA) and its response to chronic nonsteroidal antiinflammatory drugs.

250 looxygenase 2 inhibitors versus nonselective nonsteroidal antiinflammatory medications in 6-month gas

251 Interestingly, we now identified a nonsteroidal antiinflammatory selective GR agonist (SEGR

252 e small chemical changes in the structure of nonsteroidal AR ligands determine the pharmacological re

253 This first comparison of steroidal and nonsteroidal classes of aromatase inhibitors showed neit

254 reported in the accompanying paper that the nonsteroidal compound CpdX as well as its deuterated for

255 We previously reported that the nonsteroidal compound CpdX, which was initially characte

256 ding-capacity assays, we report here how two nonsteroidal compounds bind to human SHBG, and how they

257 Analogies to recent developments in nonsteroidal conjugates targeting AR are also evaluated.

258 ent tumors, such as the steroidal STX140 and nonsteroidal counterparts, acting inter alia through mic

259 methyl group was designed and synthesized as nonsteroidal CYP19 aromatase inhibitors.

260 Herein, we report for the first time that a nonsteroidal drug, ormeloxifene, has potent anticancer p

261 rapeutic agents (nonparticulate steroids and nonsteroidal drugs alike).

262 ver some 20 years, have led to steroidal and nonsteroidal drugs in numerous preclinical and clinical

263 efficacy of cilofexor (formerly GS-9674), a nonsteroidal farnesoid X receptor agonist in patients wi

264 e-activity relationship (SAR) of a series of nonsteroidal glucocorticoid receptor (GR) agonists are d

265 Seven-day treatment with inhalation of the nonsteroidal glucocorticoid receptor agonist AZD5423 eff

266 We evaluated the effect of an inhaled nonsteroidal glucocorticoid receptor agonist, AZD5423, o

267 ta[h]quinolin-3-one 3d (QCA-1093) as a novel nonsteroidal glucocorticoid receptor antagonist.

268 prednisolone and also by compound A, a novel nonsteroidal glucocorticoid receptor ligand.

269 sonicotinamides exemplified by compound 3 as nonsteroidal GPBAR1 agonists.

270 sign and pharmacology of clinically relevant nonsteroidal GR antagonists that may have greater select

271 refined classic GCs or a novel generation of nonsteroidal GR-targeting molecules, to meet the increas

272 ective and efficient method of preparing the nonsteroidal, inhaled selective glucocorticoid receptor

273 f the cardioactive terpenoid (+)-cassaine, a nonsteroidal inhibitor of Na(+)-K(+)-ATPase.

274 exes with estrone and with the first potent, nonsteroidal inhibitor.

275 dy was to identify and optimize 17beta-HSD14 nonsteroidal inhibitors as well as to disclose their str

276 These findings indicate how nonsteroidal ligands of SHBG maybe designed to modulate

277 gested opportunities for the design of other nonsteroidal ligands of SHBG.

278 C-ring, alone and in combination, as well as nonsteroidal mimics provided numerous potent VDR agonist

279 ated whether the administration of the novel nonsteroidal mineralocorticoid receptor (MR) antagonist

280 A novel series of nonsteroidal mineralocorticoid receptor (MR) antagonists

281 (-)-Finerenone is a nonsteroidal mineralocorticoid receptor antagonist curre

282 modifications were efficiently prevented by nonsteroidal MR antagonism.

283 s effort, (R)-14c was identified as a potent nonsteroidal MR antagonist (IC50 = 4.5 nM) with higher t

284 restricted to steroidal MR antagonists as a nonsteroidal MR antagonist failed to reduced blood press

285 MR blockade by the novel nonsteroidal MR antagonist, finerenone, or genetic delet

286 Finerenone, a novel nonsteroidal MR antagonist, is presently being evaluated

287 Crisaborole ointment 2% is a nonsteroidal phosphodiesterase 4 inhibitor for the treat

288 Orteronel (TAK-700) is an investigational, nonsteroidal, reversible, selective 17,20-lyase inhibito

289 However, a more direct, nonsteroidal role of LH mediating the spermiogenic pathw

290 reports have described the increasing use of nonsteroidal selective androgen receptor modulators, whi

291 gic evidence showed that AZD9496 is an oral, nonsteroidal, selective estrogen receptor antagonist and

292 A class of potent, nonsteroidal, selective indazole ether-based glucocortic

293 Finerenone, a nonsteroidal, selective mineralocorticoid receptor antag

294 Kidney Disease) evaluated the effect of the nonsteroidal, selective mineralocorticoid receptor antag

295 ting the development of orally bioavailable, nonsteroidal SERDs, currently in clinical trials.

296 to identify bile acid mimetics we uncovered nonsteroidal small molecule scaffolds that bind and inhi

297 ification and characterization of AZD9496, a nonsteroidal small-molecule inhibitor of ERalpha, which

298 tory activities of a series of steroidal and nonsteroidal sulfamate derivatives against CA IX in comp

299 fundamental need to identify nonestrogen or nonsteroidal targets for the treatment of endometriosis.

300 basis to formulate long-term nonestrogen or nonsteroidal therapy for endometriosis.